age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
45.21799
|
male
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 97,645.375
| 61,893.25
| null | 16.5
|
white
| 20.699219
| 10
| 0.894897
| 0.856934
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 35
| 65
| 12.798828
| 108
| 10
| 39.19531
| null | null | null | 0.899902
| 133
| 7.369141
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,747
| 0
|
69.75494
|
male
| 1
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 28,524.625
| 18,503.4219
| null | 27.5
|
white
| 33.398438
| 45
| 0.600952
| 0.41095
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 9
| 103
| 20.699219
| 156
| 26
| 35
| 128.5625
| null | null | 1.299805
| 137
| 7.539062
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 9
| 1
|
58.08398
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 26,848.094
| 18,352.8438
| null | 38
|
white
| 38.296875
| 63
| 0.47998
| 0.360962
| 5
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 99
| 8.199219
| 130
| 40
| 37.59375
| 142.84375
| null | 26.898438
| 1.599854
| 134
| 7.299805
| null | null | null | null | null |
<2 mo. follow-up
| 2.318359
| 5
| 1
|
68.30896
|
male
| 0
| 15
|
Lung Cancer
|
Cancer
| 1
| 11
|
$11-$25k
| 0
| 19,022.094
| 13,289.7422
| null | 11.333328
|
black
| 15.5
| 11
| 0.728882
| 0.45697
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 15
| 81
| 4.399414
| 80
| 24
| 36.5
| null | 3.299805
| 0.5
| 1.099854
| 140
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 266
| 1
|
49.56299
|
male
| 0
| 26
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 20,963.141
| 16,049.4844
| null | 5.5
|
white
| 23.597656
| 17
| 0.600952
| 0.282959
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.5
|
no dnr
| 26
| 75
| 10.199219
| 100
| 24
| 35.29688
| null | null | 0.899902
| 0.899902
| 129
| null | null | null | null | 2
| 0
|
adl>=4 (>=5 if sur)
| 0
| 91
| 1
|
45.89499
|
female
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
$11-$25k
| 100
| 105,779.312
| 68,334.9375
| null | 32
|
white
| 19.296875
| 18
| 0.554932
| 0.441956
| 16
| 0
| 0
|
no
| null | null |
no dnr
| 14
| 153
| 6.599609
| 102
| 14
| 40
| 297.125
| null | null | 0.699951
| 142
| 7.399414
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 14
| 1
|
57.51099
|
female
| 1
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 100
| 74,188.188
| 50,404.625
| null | 38.666657
|
black
| 36.5
| 59
| 0.08699
| 0.033997
| 3
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 15
| 63
| 21.199219
| 80
| 11
| 36.69531
| 216
| null | 15.898438
| 2.199707
| 122
| 7.40918
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 24
| 1
|
76.03595
|
male
| 0
| 68
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$11-$25k
| 0
| 194,034
| 119,902.875
| null | 23.5
|
white
| 31.199219
| 56
| 0.412964
| 0.292969
| 40
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 68
| 55
| 10.398438
| 126
| 28
| 38.5
| 272
| 3
| 1.199951
| 3
| 149
| 7.469727
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 1,485
| 1
|
72.86798
|
female
| 0
| 31
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| 70,304.062
| 49,123.8125
| null | 29
|
white
| 23.597656
| 36
| 0.679932
| 0.510986
| 4
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 31
| 131
| 14.798828
| 144
| 28
| 38.5
| 270
| 2.5
| null | 0.699951
| 132
| 7.439453
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,007
| 1
|
46.15198
|
female
| 1
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 15
|
>$50k
| 0
| 68,531.375
| 49,419.8125
| null | 20
|
white
| 23.796875
| 30
| 0.810913
| 0.747925
| 26
| 1
| 0
|
no
| 0.2
| 0.05
|
dnr after sadm
| 21
| 117
| 15.599609
| 74
| 22
| 36.09375
| 386.625
| null | null | 7.899414
| 132
| 7.369141
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 30
| 1
|
72.94196
|
male
| 1
| 77
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 224,667.25
| 154,288
| null | 32
|
white
| 29.398438
| 36
| 0.591919
| 0.40094
| 1
| 0
| 0
|
yes
| 0.6
| 0.6
|
dnr after sadm
| 60
| 127
| 19.597656
| 130
| 34
| 37.69531
| 260
| 2.5
| null | 0.799927
| 148
| 7.429688
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 77
| 1
|
56.01398
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
$11-$25k
| 0
| 4,446.297
| 3,174.543
| null | 3
|
white
| 20
| 21
| 0.884888
| 0.807983
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 60
| 5.699219
| 124
| 24
| 36.09375
| null | null | 0.5
| 1.199951
| 142
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 906
| 1
|
47.36798
|
male
| 1
| 12
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 10
|
under $11k
| 26
| 32,115.641
| 23,570.2656
| null | 40
|
white
| 33.5
| 54
| 0.498962
| 0.296997
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 12
| 109
| 10.798828
| 114
| 12
| 37.79688
| 433.3125
| 2
| 31.097656
| 1.599854
| 131
| 7.5
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 12
| 1
|
60.39697
|
male
| 0
| 22
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 8
| null | 0
| 27,399.438
| 19,980.3125
| null | 19.666656
|
black
| 32.195313
| 45
| 0.695923
| 0.531982
| 1
| 0
| 0
|
no
| 0.6
| 0.4
|
dnr after sadm
| 17
| 61
| 5
| 118
| 25
| 35.59375
| null | null | null | 4.099609
| 130
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.091309
| 31
| 1
|
66.35199
|
female
| 0
| 16
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 0
| 26,706.297
| 18,707.6562
| null | 18
|
white
| 21.898438
| 29
| 0.836914
| 0.73291
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 16
| 115
| 27.398438
| 114
| 26
| 38
| 210
| null | 0.399963
| 0.799927
| 140
| 7.399414
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 310
| 1
|
46.133
|
male
| 0
| 65
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 12
|
$11-$25k
| 0
| 135,704.5
| 95,831.5
| null | 16.25
|
white
| 19.5
| 18
| 0.909912
| 0.8479
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 65
| 63
| 10.298828
| 106
| 24
| 36.59375
| 252
| null | 0.699951
| 1.299805
| 149
| 7.449219
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,740
| 0
|
61.33298
|
male
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 22,090.984
| 16,710.5625
| null | 17.666656
|
white
| 38.5
| 56
| 0.455994
| 0.254944
| 1
| 0
| 0
|
yes
| 0.5
| 0.3
|
no dnr
| 15
| 53
| 6.599609
| 112
| 36
| 35.29688
| 210
| null | null | 2.099609
| 125
| 7.489258
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,740
| 0
|
67.50195
|
male
| 1
| 95
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| null | null | null | 47
|
white
| 43.09375
| 70
| 0.316956
| 0.203979
| 2
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 95
| 44
| 14.298828
| 168
| 27
| 39
| 116.25
| null | null | 2.099609
| 142
| 7.319336
| null | null | null | null | null | null | 1.993652
| 95
| 1
|
60.03799
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 6
|
$11-$25k
| 0
| 62,400.594
| 41,833.6875
| null | 46
|
white
| 41.898438
| 55
| 0.405945
| 0.286987
| 2
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 21
| 50
| 5.899414
| 140
| 31
| 40.29688
| 116.3125
| null | null | 1.399902
| 128
| 7.419922
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,214
| 1
|
30.92999
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 18
|
$11-$25k
| 0
| 17,066.641
| 12,493.8516
| null | 13.5
|
black
| 23.097656
| 31
| 0.894897
| 0.856934
| 2
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 9
| 117
| 17.5
| 100
| 20
| 37.39844
| 495.1875
| null | null | 7.199219
| 136
| 7.419922
| null | null | null | 4
| 0
|
no(M2 and SIP pres)
| 0
| 1,735
| 0
|
68.53699
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 6
|
under $11k
| 0
| 11,333.148
| 9,014.3438
| null | 11.5
|
white
| 15.398438
| 32
| 0.894897
| 0.824951
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 9
| 65
| 10.298828
| 70
| 28
| 38.39844
| null | null | null | 1.199951
| 135
| null | null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 31
| 1
|
62.853
|
male
| 0
| 50
|
Coma
|
Coma
| 0
| 16
|
>$50k
| 100
| 67,972.5
| 48,889.6562
| null | 30
|
white
| 24.898438
| 35
| 0.202972
| 0.141998
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 16
| 130
| 14.5
| 116
| 8
| 37.79688
| 356.625
| 2.5
| 0.5
| 4.299805
| 137
| 7.369141
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.367188
| 211
| 1
|
84.79895
|
male
| 1
| 6
|
Coma
|
Coma
| 2
| 16
|
under $11k
| 100
| 14,790.844
| 11,221.7109
| null | 35
|
black
| 21.898438
| 32
| 0.096985
| 0.057999
| 1
| 0
| 1
|
no
| 0.2
| 0.1
|
no dnr
| 6
| 140
| 13.298828
| 124
| 9
| 36
| 280.9375
| 2.699707
| 1
| 1.199951
| 141
| 7.359375
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 6
| 1
|
75.71295
|
male
| 0
| 14
|
Colon Cancer
|
Cancer
| 2
| null |
>$50k
| 26
| 21,044.891
| 14,540.7812
| null | 16
|
black
| 46
| 60
| 0.030998
| 0
| 1
| 1
| 0
|
metastatic
| 0.8
| 0.8
|
no dnr
| 14
| 127
| 7.599609
| 116
| 8
| 34
| 393.3125
| 2.299805
| 3.399902
| 2.599609
| 136
| 7.319336
| null | null | null | 1
| 2
|
no(M2 and SIP pres)
| 2
| 477
| 1
|
60.55298
|
male
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 7
|
$11-$25k
| 0
| 139,645.375
| 93,788.5625
| null | 31.25
|
white
| 34.296875
| 79
| 0.635986
| 0.533936
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 38
| 56
| 21.898438
| 150
| 38
| 40.19531
| 240
| 2
| null | 2.699707
| 151
| 7.40918
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,529
| 1
|
62.87198
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 13
|
$11-$25k
| 0
| 5,380.949
| 3,435.7266
| null | 11
|
white
| 23.097656
| 13
| 0.723999
| 0.448975
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.1
|
no dnr
| 5
| 100
| 13.099609
| 84
| 20
| 36.89844
| null | 2.799805
| 0.399963
| 0.899902
| 135
| null | null | null | null | 0
| null | null | 0.4948
| 60
| 1
|
43.73199
|
female
| 0
| 10
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 13
|
under $11k
| 41
| 23,367.25
| 16,260.5391
| null | 21
|
white
| 17.097656
| 27
| 0.814941
| 0.699951
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 10
| 121
| 5.699219
| 76
| 26
| 36.39844
| 376.625
| 2
| 2.399902
| 0.799927
| 140
| 7.439453
| null | null | null | null | 1
|
SIP>=30
| 1
| 811
| 1
|
72.64899
|
female
| 1
| 6
|
Coma
|
Coma
| 1
| 7
|
under $11k
| 94
| 18,816.297
| 13,245.6719
| null | 41
|
black
| 23.097656
| 36
| 0.163971
| 0.109985
| 2
| 0
| 0
|
no
| 0.01
| 0.000001
|
dnr after sadm
| 4
| 80
| 22.199219
| 126
| 32
| 38.09375
| 285
| 2.399902
| 0.399963
| 1.599854
| 134
| 7.40918
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 6
| 1
|
44.50897
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 13
|
$11-$25k
| 0
| 7,222.297
| 5,163.0391
| null | 7
|
black
| 13.898438
| 9
| 0.881958
| 0.73291
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 7
| 103
| 6.299805
| 64
| 16
| 37.29688
| null | null | 0.399963
| 1.099854
| 135
| null | null | null | null | 0
| 0
| null | 0
| 563
| 1
|
49.11398
|
female
| 1
| 4
|
Coma
|
Coma
| 0
| 16
| null | 100
| 13,132.547
| 10,200.2109
| null | 33
|
white
| 21.699219
| 31
| 0.435974
| 0.362
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 3
| 193
| 16.699219
| 68
| 16
| 38.5
| 296.625
| null | 0.399963
| 3.399902
| 148
| 7.639648
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
61.33099
|
male
| 0
| 18
|
Lung Cancer
|
Cancer
| 2
| 10
|
$11-$25k
| 0
| 14,604.5
| 11,523.4062
| null | 10.666664
|
white
| 22.199219
| 18
| 0.600952
| 0.282959
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 18
| 93
| 9.5
| 124
| 28
| 36.79688
| null | 3.399902
| 0.299988
| 0.699951
| 140
| null | null | null | null | 2
| 2
|
adl>=4 (>=5 if sur)
| 2
| 213
| 1
|
75.33698
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 6
|
$11-$25k
| 0
| null | null | null | 48
|
white
| 32.5
| 52
| 0.428955
| 0.30896
| 7
| 0
| 0
|
yes
| 0.3
| 0.2
|
dnr after sadm
| 8
| 57
| 10
| 118
| 14
| 35.79688
| 140
| null | 0.199982
| 2.299805
| 139
| 7.469727
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 9
| 1
|
63.87097
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 5,620.898
| 3,797.3769
| null | 18
|
black
| 18.5
| 13
| 0.79895
| 0.572998
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
no dnr
| 6
| 82
| 15.699219
| 60
| 20
| 35.79688
| null | null | 0.399963
| 1
| 143
| null | null | null | null | null | null | null | 1.759522
| 61
| 1
|
46.146
|
female
| 0
| 93
|
Coma
|
Coma
| 0
| null | null | 55
| 110,333.188
| 79,961.75
| null | 16.5
|
other
| 23.097656
| 35
| 0.637939
| 0.576904
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 12
| 114
| 22.699219
| 130
| 33
| 37.79688
| 226.65625
| 2.699707
| 1.599854
| 1.299805
| 143
| 7.479492
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,728
| 0
|
62.642
|
male
| 1
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 9
| 134,189.125
| 86,933.5625
| null | 32.666657
|
white
| 27.398438
| 45
| 0.642944
| 0.541992
| 29
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 16
| 73
| 7
| 72
| 32
| 35.69531
| 266.625
| null | null | 2.199707
| 126
| 7.539062
| null | null | null | null | null |
<2 mo. follow-up
| 3.343262
| 21
| 1
|
60.71198
|
male
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 11
|
under $11k
| 0
| 18,054.734
| 12,643.5312
| null | 28
|
white
| 28.796875
| 40
| 0.772949
| 0.638916
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 2
| 59
| 17.097656
| 128
| 29
| 35.59375
| 186.65625
| null | null | 0.799927
| 136
| 7.379883
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 610
| 1
|
48.41599
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 6,101.648
| 3,718.8301
| null | 7
|
white
| 15.099609
| 11
| 0.776978
| 0.534912
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.2
|
no dnr
| 5
| 113
| 14.298828
| 116
| 24
| 36.59375
| null | 3.899902
| 0.299988
| 0.899902
| 141
| null | null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 256
| 1
|
79.33997
|
female
| 1
| 8
|
Coma
|
Coma
| 0
| 14
|
$11-$25k
| 61
| 16,749.594
| 11,828.3281
| null | 20.5
|
white
| 19.097656
| 21
| 0.401978
| 0.328979
| 1
| 0
| 0
|
no
| 0.2
| 0.15
|
dnr after sadm
| 5
| 110
| 15.699219
| 122
| 8
| 38.09375
| 340
| null | 0.899902
| 1.199951
| 140
| 7.479492
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
80.10095
|
male
| 1
| 11
|
Coma
|
Coma
| 2
| 7
|
under $11k
| 44
| 29,686.375
| 21,820.5625
| null | 39.5
|
white
| 23.296875
| 38
| 0.358948
| 0.28595
| 1
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 2
| 103
| 16.796875
| 60
| 32
| 36.39844
| 283.3125
| null | null | 2.199707
| 138
| 7.429688
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 11
| 1
|
83.02496
|
female
| 1
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
under $11k
| 0
| 22,340.797
| 17,646.4531
| null | 13.5
|
black
| 20.199219
| 25
| 0.800903
| 0.734985
| 1
| 1
| 0
|
no
| 0.25
| 0.2
|
dnr after sadm
| 14
| 83
| 13.699219
| 76
| 22
| 36.29688
| 300
| null | 1.099854
| 1.699951
| 148
| 7.369141
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 26
| 1
|
51.89899
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
>$50k
| 0
| 20,532.094
| 15,660.5156
| null | 20.5
|
white
| 26.699219
| 27
| 0.813965
| 0.751953
| 1
| 0
| 0
|
no
| 0.99
| 0.98
|
no dnr
| 10
| 99
| 15.699219
| 112
| 28
| 38.19531
| 180
| null | null | 1.399902
| 130
| 7.489258
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,718
| 0
|
33.54999
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 7,093.848
| 5,116.8594
| null | 18
|
white
| 23.796875
| 24
| 0.780884
| 0.541992
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 6
| 73
| 15.199219
| 140
| 22
| 39.59375
| null | null | null | 0.599976
| 135
| null | null | null | null | 0
| null | null | 0.4948
| 191
| 1
|
21.043
|
female
| 1
| 4
|
Coma
|
Coma
| 0
| 15
|
$25-$50k
| 100
| 15,271.648
| 12,390.4844
| null | 42
|
white
| 53.398438
| 67
| 0.007
| 0.002
| 1
| 0
| 0
|
no
| 0.85
| 0.84
|
no dnr
| 4
| 46
| 12.298828
| 134
| 10
| 32.5
| 112.5
| 3.599609
| 0.799927
| 0.799927
| 175
| 7.599609
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
46.09998
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 11
|
under $11k
| 0
| 2,824.148
| 2,343.2715
| null | 6
|
black
| 14.398438
| 6
| 0.939941
| 0.896973
| 1
| 0
| 0
|
no
| 0.95
| 0.6
|
no dnr
| 4
| 97
| 6.399414
| 72
| 24
| 36.5
| null | null | 1.399902
| 1.099854
| 141
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,714
| 0
|
50.09998
|
male
| 0
| 3
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 4
|
$25-$50k
| 0
| 2,701.25
| 1,954.959
| null | 3
|
white
| 19.699219
| 19
| 0.843994
| 0.74292
| 1
| 0
| 0
|
no
| null | 0.5
|
no dnr
| 3
| 81
| 5
| 86
| 18
| 36.59375
| null | 3.599609
| 3.199707
| 1.299805
| 130
| null | null | null | null | 0
| 0
| null | 0
| 1,714
| 0
|
66.87695
|
male
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 5
|
$11-$25k
| 0
| 24,346.391
| 18,417.8594
| null | 11.666664
|
black
| 23.097656
| 30
| 0.819946
| 0.706909
| 1
| 0
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 16
| 70
| 13.099609
| 120
| 22
| 36.5
| null | null | null | 1.599854
| 135
| null | null | null | null | 0
| 0
|
SIP>=30
| 0
| 189
| 1
|
58.55399
|
male
| 1
| 4
|
Lung Cancer
|
Cancer
| 1
| 11
|
$25-$50k
| 100
| 4,597.379
| 3,382.6074
| null | 17
|
white
| 38.59375
| 66
| 0
| 0
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
dnr after sadm
| 2
| 73
| 0.399963
| 114
| 40
| 38.39844
| 252.375
| 2.199707
| 2.199707
| 0.899902
| 160
| 7.489258
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 4
| 1
|
32.77499
|
female
| 0
| 41
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
| null | 26
| 72,100.438
| 52,992.1875
| null | 19
|
black
| 22.898438
| 31
| 0.80188
| 0.736938
| 30
| 0
| 0
|
no
| 0.25
| 0.15
|
no dnr
| 41
| 147
| 22.398438
| 108
| 8
| 38.5
| 388
| null | 2.099609
| 1.699951
| 148
| 7.369141
| null | null | null | null | 5
|
SIP>=30
| 5
| 989
| 1
|
79.82196
|
male
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 5
| null | 0
| 26,503.984
| 17,639.2812
| null | 16.666656
|
black
| 24.5
| 31
| 0.74292
| 0.594971
| 1
| 0
| 0
|
no
| 0.7
| 0.4
|
dnr after sadm
| 10
| 71
| 18
| 108
| 24
| 36.39844
| 280.9375
| null | 1.099854
| 1.399902
| 129
| 7.529297
| null | null | null | 3
| null |
no(M2 and SIP pres)
| 2.511099
| 1,255
| 1
|
66.97595
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
$11-$25k
| 0
| 17,114.547
| 12,349.8984
| null | 9.5
|
white
| 34.195313
| 36
| 0.522949
| 0.406982
| 7
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 129
| 11.099609
| 100
| 20
| 37.69531
| 120.40625
| null | null | 5.199219
| 128
| 7.459961
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,708
| 0
|
78.69397
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 100
| 17,514.391
| 10,762.4609
| null | 49
|
black
| 66.796875
| 100
| 0
| 0
| 1
| 0
| 0
|
yes
| 0
| 0
|
no dnr
| 3
| 27
| 9.699219
| 26
| 24
| 35.5
| 41
| 1.599854
| 1.099854
| 4.799805
| 164
| 7.149414
| null | null | null | null | null |
<2 mo. follow-up
| 2.666992
| 3
| 1
|
61.58499
|
female
| 0
| 12
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 37
| 21,559.438
| 15,395.9688
| null | 28.5
|
white
| 22.296875
| 33
| 0.60498
| 0.415955
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 12
| 109
| 9.398438
| 68
| 25
| 38.29688
| 336.625
| 3.399902
| 13.798828
| 0.799927
| 142
| 7.429688
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,708
| 0
|
41.336
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$25-$50k
| 0
| 14,625.898
| 10,672.5547
| null | 16.5
|
white
| 23
| 36
| 0.881958
| 0.840942
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 11
| 77
| 11.5
| 110
| 31
| 36.19531
| 216.65625
| 2
| 0.5
| 0.699951
| 139
| 7.439453
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,707
| 0
|
80.69299
|
female
| 1
| 23
|
Coma
|
Coma
| 0
| 8
| null | 100
| 19,765.344
| 16,017.7656
| null | 11.666664
|
black
| 25.199219
| 34
| 0.052994
| 0.028
| 2
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 2
| 117
| 16
| 120
| 30
| 38.79688
| 342.8125
| null | null | 0.599976
| 131
| 7.509766
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 23
| 1
|
55.66299
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 0
|
under $11k
| 0
| 4,980.25
| 3,698.125
| null | 7
|
black
| 15.798828
| 17
| 0.917969
| 0.860962
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 4
| 90
| null | 68
| 22
| 36.89844
| null | 3.399902
| 0.799927
| 1.5
| 139
| null | null | null | null | 0
| null | null | 0.4948
| 1,706
| 0
|
34.53
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 14
| null | 0
| 6,055.898
| 4,246.4609
| null | 6
|
black
| 18.699219
| 14
| 0.916992
| 0.859985
| 1
| 1
| 0
|
yes
| 1
| 0.5
|
no dnr
| 4
| 71
| 12.5
| 96
| 20
| 36.29688
| null | null | 1.399902
| 0.799927
| 141
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,705
| 0
|
62.30499
|
male
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 49,924.438
| 33,067.125
| null | 44
|
white
| 29.398438
| 33
| 0.605957
| 0.5
| 6
| 0
| 0
|
yes
| 0.5
| 0.4
|
dnr after sadm
| 11
| 113
| 12.298828
| 106
| 28
| 38.5
| 117.5
| null | 1.399902
| 0.899902
| 130
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 12
| 1
|
78.58496
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 89
| 14,208.648
| 10,709.4922
| null | 37
|
white
| 84.390625
| 123
| 0
| 0
| 1
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 2
| 0
| 80.09375
| 0
| 0
| 38.19531
| 53.32812
| 1.699951
| 2.5
| 7.399414
| 142
| 7.15918
| null | null | null | null | null |
<2 mo. follow-up
| 1.578613
| 3
| 1
|
73.56299
|
male
| 0
| 28
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 54,476.031
| 36,734.5625
| null | 26.75
|
white
| 45.09375
| 86
| 0.122986
| 0.054993
| 1
| 0
| 0
|
yes
| 0.2
| 0.05
|
dnr after sadm
| 16
| 47
| 0.099991
| 190
| 32
| 36.09375
| 304
| 2.299805
| 0.299988
| 3.099609
| 143
| 7.40918
| null | null | null | null | null | null | 2.237793
| 139
| 1
|
57.793
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 100
| null | null | null | 47
|
white
| 74.59375
| 105
| 0
| 0
| 2
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 3
| 23
| 6.699219
| 0
| 24
| 36
| 65
| 2.799805
| 5.5
| 6
| 164
| 7.129883
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 3
| 1
|
41.16098
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 4,960
| 3,366.8867
| null | 22
|
white
| 14.099609
| 5
| 0.884888
| 0.738892
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 5
| 85
| 7.5
| 78
| 16
| 36.39844
| null | null | 0.299988
| 0.799927
| 140
| null | null | null | null | null | null | null | 1.640869
| 253
| 1
|
62.81198
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 0
| 84,675.625
| 56,459.8438
| null | 17
|
white
| 28.398438
| 25
| 0.662964
| 0.565918
| 19
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 11
| 61
| 14.798828
| 118
| 30
| 36.29688
| 190
| 2.5
| null | 0.5
| 134
| 7.439453
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,013
| 1
|
62.70798
|
male
| 1
| 7
|
Lung Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 26
| 3,095.148
| 2,995.7598
| null | 6.5
|
white
| 16.597656
| 5
| 0.622925
| 0.309998
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 1
| 80
| 9.898438
| 70
| 22
| 36
| null | null | null | 1
| 135
| null | null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 7
| 1
|
50.29199
|
male
| 0
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
>$50k
| 0
| 31,121.438
| 22,044.7344
| null | 22
|
white
| 26.398438
| 64
| 0.488953
| 0.370972
| 17
| 0
| 0
|
metastatic
| 1
| 0.5
|
no dnr
| 8
| 59
| 31
| 102
| 22
| 36.79688
| 396
| 1.599854
| 0.899902
| 7.199219
| 131
| 7.389648
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,699
| 0
|
79.81696
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 20
|
$25-$50k
| 0
| 8,032.547
| 6,131.3477
| null | 10
|
white
| 18.097656
| 19
| 0.81189
| 0.694946
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 10
| 97
| 11.599609
| 102
| 24
| 37.29688
| 247.59375
| null | null | 1.399902
| 138
| 7.329102
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,697
| 0
|
63.64398
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 16
|
$11-$25k
| 0
| 7,005.727
| 4,714.8516
| null | 10
|
white
| 32.5
| 31
| 0.495972
| 0.175995
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
no dnr
| 7
| 113
| 11.099609
| 94
| 16
| 36.29688
| null | 2.599609
| 2
| 1.599854
| 131
| null | null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 19
| 1
|
57.67297
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 16
|
$25-$50k
| 0
| 12,842.945
| 9,616.5078
| null | 16
|
white
| 31.398438
| 41
| 0.696899
| 0.531982
| 1
| 0
| 0
|
yes
| 0.6
| 0.5
|
no dnr
| 9
| 111
| 7.399414
| 110
| 21
| 36.69531
| 268
| 2.599609
| null | 2.799805
| 155
| 7.30957
| null | null | null | null | 4
|
no(M2 and SIP pres)
| 4
| 1,697
| 0
|
58.97598
|
male
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
| null | 9
| 209,815.5
| 142,808.875
| null | 35.75
|
white
| 27.296875
| 36
| 0.658936
| 0.560913
| 52
| 0
| 0
|
no
| 0.5
| 0.45
|
no dnr
| 26
| 73
| 18.296875
| 74
| 8
| 35.5
| 250
| 2.799805
| null | 8.099609
| 128
| 7.419922
| null | null | null | null | 0
|
SIP>=30
| 0
| 329
| 1
|
63.89899
|
female
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 4
|
under $11k
| 0
| 68,388.125
| 44,266.1875
| null | 40
|
black
| 39.695313
| 61
| 0.442993
| 0.323975
| 2
| 1
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 17
| 71
| 18.398438
| 110
| 40
| 35.79688
| 109.07812
| null | null | 2.299805
| 129
| 7.469727
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
49.37198
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 7,472.5
| 5,169.1484
| null | 11
|
white
| 18
| 6
| 0.831909
| 0.632935
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 7
| 87
| 12.199219
| 56
| 16
| 36.59375
| null | null | 0.899902
| 0.799927
| 142
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 324
| 1
|
68.20496
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 20
|
$25-$50k
| 0
| 6,022
| 4,329.4102
| null | 6
|
other
| 21.796875
| 41
| 0.830933
| 0.723999
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 5
| 77
| 9.898438
| 102
| 20
| 36.19531
| 328.5625
| 3.599609
| 0.399963
| 2.399902
| 137
| 7.439453
| null | null | null | 1
| 2
|
no(M2 and SIP pres)
| 2
| 653
| 1
|
57.91397
|
female
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 9
| 38,281.625
| 27,834.9375
| null | 17.666656
|
hispanic
| 23
| 35
| 0.766968
| 0.691895
| 12
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 24
| 119
| 14.199219
| 116
| 40
| 38.29688
| 213.3125
| null | 0.299988
| 0.799927
| 134
| 7.40918
| null | null | null | null | 2
| null | 2
| 837
| 1
|
68.37195
|
female
| 1
| 9
|
Coma
|
Coma
| 0
| null | null | 94
| 27,641.391
| 20,191.5
| null | 25.5
|
white
| 21.296875
| 19
| 0.231995
| 0.166992
| 3
| 0
| 0
|
no
| null | null |
dnr after sadm
| 4
| 110
| 9.699219
| 42
| 11
| 36.89844
| 250
| null | null | 0.599976
| 148
| 7.479492
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
69.19897
|
male
| 0
| 37
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 91,875.625
| 64,329.7188
| null | 18.75
|
white
| 22.898438
| 34
| 0.588989
| 0.396973
| 12
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 37
| 101
| 14.199219
| 108
| 22
| 36.79688
| 285.6875
| 2.399902
| 4.399414
| 1
| 148
| 7.55957
| null | null | null | null | 0
| null | 0
| 1,682
| 0
|
33.07898
|
male
| 1
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$11-$25k
| 0
| 164,121.625
| 108,221.125
| null | 36.75
|
black
| 21.5
| 34
| 0.909912
| 0.87793
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
dnr after sadm
| 27
| 73
| 16.097656
| 72
| 10
| 36
| 228.5625
| null | 1
| 11.398438
| 133
| 7.319336
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 34
| 1
|
72.64899
|
male
| 1
| 4
|
Coma
|
Coma
| 0
| null | null | 89
| 12,858.797
| 9,592.6719
| null | 37
|
white
| 17.699219
| 22
| 0.367981
| 0.294983
| 1
| 0
| 0
|
no
| 0.02
| 0.000008
|
dnr after sadm
| 4
| 120
| 13.199219
| 58
| 8
| 38.19531
| 197.125
| null | null | 1.299805
| 139
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 2.059082
| 4
| 1
|
69.01794
|
female
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
$11-$25k
| 0
| 57,983.438
| 39,160.5
| null | 18
|
white
| 20.5
| 19
| 0.80896
| 0.744995
| 5
| 0
| 0
|
no
| 0.8
| 0.65
|
no dnr
| 18
| 80
| 10
| 90
| 12
| 38.5
| 242.84375
| null | null | 2.099609
| 131
| 7.479492
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 18
| 1
|
46.13797
|
male
| 0
| 81
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 9
| 165,522
| 113,269.062
| null | 41
|
white
| 31.597656
| 38
| 0.698975
| 0.60791
| 3
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 81
| 151
| 22.597656
| 136
| 25
| 38.89844
| 116
| 3.299805
| 1.799805
| 0.899902
| 132
| 7.449219
| null | null | null | null | null | null | 2.230469
| 1,681
| 0
|
63.422
|
male
| 0
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 26
| 56,185.094
| 41,615.7812
| null | 25.75
|
white
| 37.398438
| 53
| 0.346985
| 0.22998
| 4
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 34
| 126
| 8.798828
| 104
| 8
| 35.29688
| 142.84375
| 2.699707
| 4.399414
| 7
| 128
| 7.459961
| null | null | null | null | null | null | 2.65625
| 72
| 1
|
65.89496
|
female
| 0
| 29
|
Coma
|
Coma
| 0
| 9
|
$11-$25k
| 44
| 97,451.25
| 65,060.1875
| null | 30
|
white
| 16.199219
| 12
| 0.595947
| 0.530884
| 12
| 0
| 0
|
no
| null | null |
no dnr
| 29
| 125
| 10.599609
| 70
| 9
| 37.69531
| 331.375
| null | null | 0.699951
| 134
| 7.469727
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,679
| 0
|
64.10394
|
female
| 1
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 65,610.625
| 42,855.7812
| null | 47
|
white
| 24.5
| 23
| 0.787964
| 0.718994
| 2
| 0
| 0
|
no
| 0.6
| 0.5
|
dnr after sadm
| 13
| 65
| 15.298828
| 118
| 10
| 36.59375
| 167.5
| 3.199707
| 1
| 1
| 136
| 7.509766
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 15
| 1
|
68.20496
|
female
| 0
| 15
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 16
| null | 0
| 89,705.938
| 60,473.875
| null | 25.666656
|
white
| 28.296875
| 33
| 0.625977
| 0.440979
| 42
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 15
| 136
| 10.099609
| 54
| 26
| 36.19531
| 145.6875
| 3.199707
| null | 1.399902
| 133
| 7.359375
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,495
| 1
|
42.88797
|
male
| 0
| 49
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
under $11k
| 9
| 107,267.375
| 73,935.5
| null | 26.5
|
black
| 29.898438
| 48
| 0.698975
| 0.608887
| 18
| 0
| 0
|
no
| null | null |
no dnr
| 49
| 127
| 28.097656
| 154
| 36
| 36.09375
| 226.65625
| 4.299805
| 4.699219
| 0.699951
| 138
| 7.439453
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.874512
| 1,364
| 1
|
70.51599
|
female
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| 8
|
$11-$25k
| 0
| 7,154.898
| 5,441.2773
| null | 12.5
|
white
| 19.597656
| 11
| 0.638916
| 0.328979
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 8
| 97
| 8.298828
| 68
| 16
| 35.29688
| null | null | 0.299988
| 0.5
| 136
| null | null | null | null | 4
| 5
| null | 5
| 60
| 1
|
74.09998
|
female
| 0
| 16
|
Lung Cancer
|
Cancer
| 1
| null |
under $11k
| 0
| 11,191.844
| 8,596.3125
| null | 8.333328
|
black
| 19.398438
| 22
| 0.632935
| 0.32196
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 2
| 137
| 13.699219
| 112
| 24
| 36.39844
| null | null | 0.299988
| 1
| 137
| null | null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 78
| 1
|
69.10895
|
male
| 0
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
$25-$50k
| 9
| 53,654.719
| 39,518.2812
| null | 20
|
white
| 24.199219
| 34
| 0.625977
| 0.521973
| 15
| 0
| 0
|
yes
| 0.2
| 0.05
|
dnr after sadm
| 9
| 119
| 6.599609
| 110
| 50
| 38
| 296
| null | null | 0.599976
| 134
| 7.489258
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 37
| 1
|
72.73895
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
$25-$50k
| 9
| 30,448.625
| 20,684.0625
| null | 21
|
white
| 21
| 36
| 0.753906
| 0.67688
| 7
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 72
| 12.099609
| 64
| 30
| 36.79688
| 196.65625
| 3
| null | 1.399902
| 136
| 7.479492
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,673
| 0
|
68.62994
|
male
| 1
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$25-$50k
| 9
| 128,551.688
| 84,274.5625
| null | 46
|
white
| 37.195313
| 68
| 0.464966
| 0.345947
| 1
| 0
| 0
|
no
| 0.3
| 0.3
|
dnr after sadm
| 27
| 68
| 29.597656
| 144
| 40
| 40.59375
| 71
| null | 0.399963
| 1.599854
| 136
| 7.40918
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 33
| 1
|
56.30899
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 16,926.094
| 12,640.9609
| null | 16
|
white
| 26.5
| 23
| 0.697998
| 0.60791
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
no dnr
| 12
| 81
| 11.298828
| 118
| 32
| 37.09375
| 144.875
| null | 0.699951
| 1.099854
| 136
| 7.449219
| null | null | null | 1
| 2
|
adl>=4 (>=5 if sur)
| 2
| 86
| 1
|
75.12695
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 6,113.828
| 4,340.6133
| null | 20
|
black
| 19.199219
| 36
| 0.781982
| 0.650879
| 1
| 1
| 0
|
yes
| null | null |
no dnr
| 6
| 100
| 15
| 76
| 40
| 36
| 252.375
| null | 0.199982
| 0.799927
| 138
| 7.419922
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 1,673
| 0
|
65.80194
|
male
| 1
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$11-$25k
| 26
| 5,412.527
| 3,704.7129
| null | 16
|
white
| 24.796875
| 18
| 0.665894
| 0.491943
| 1
| 0
| 0
|
yes
| 0.2
| 0.05
|
dnr after sadm
| 1
| 120
| 11.798828
| 124
| 24
| 35.09375
| 364
| null | null | 0.899902
| 135
| 7.25
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
42.67798
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 10
|
under $11k
| 0
| 3,498.949
| 2,964.6816
| null | 9
|
black
| 21.898438
| 32
| 0.899902
| 0.830933
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 6
| 97
| 7.599609
| 70
| 21
| 36.39844
| 357.125
| null | 1.199951
| 3.099609
| 134
| 7.389648
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 869
| 1
|
47.51797
|
female
| 0
| 8
|
Lung Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 10,569.695
| 7,576.1016
| null | 15.5
|
white
| 22
| 26
| 0.645996
| 0.338989
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.9
|
no dnr
| 8
| 99
| 20.199219
| 74
| 10
| 36.69531
| 366.625
| 3.199707
| 0.5
| 0.699951
| 143
| 7.459961
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 226
| 1
|
28.211
|
male
| 1
| 14
|
Coma
|
Coma
| 1
| 12
| null | 100
| 75,495.125
| 52,903.625
| null | 28
|
black
| 27.5
| 52
| 0.372986
| 0.299988
| 11
| 0
| 0
|
no
| null | null |
dnr after sadm
| 14
| 133
| 30.097656
| 126
| 12
| 38.69531
| 172.5
| null | 0.799927
| 1.899902
| 143
| 7.5
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 14
| 1
|
77.89496
|
male
| 0
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 9
| 33,176.25
| 26,470.5781
| null | 15.5
|
black
| 29.296875
| 51
| 0.616943
| 0.511963
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 40
| 60
| 27.597656
| 104
| 10
| 36.39844
| 263.3125
| null | 0.299988
| 5.799805
| 131
| 7.379883
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.169434
| 1,394
| 1
|
56.12299
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
$25-$50k
| 55
| 59,076.75
| 39,979.8125
| null | 31
|
white
| 33.09375
| 47
| 0.346985
| 0.230988
| 7
| 1
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 23
| 61
| 10.199219
| 74
| 12
| 35.09375
| 83.0625
| null | 0.099991
| 4.899414
| 138
| 7.519531
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,213
| 1
|
72.81897
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 51,952.594
| 36,315.0625
| null | 29.666656
|
white
| 32.195313
| 51
| 0.524902
| 0.409973
| 10
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 20
| 59
| 15.798828
| 48
| 22
| 37.5
| 176.65625
| null | null | 2.899902
| 128
| 7.5
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 194
| 1
|
74.80396
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 4
|
$11-$25k
| 0
| 24,017.844
| 16,611.9844
| null | 18.5
|
white
| 17.296875
| 33
| 0.849976
| 0.797974
| 2
| 0
| 0
|
no
| 0.75
| 0.421875
|
no dnr
| 12
| 64
| 7.599609
| 104
| 26
| 38.29688
| 220
| null | 0.5
| 1.399902
| 135
| 7.459961
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,666
| 0
|
65.39099
|
male
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
>$50k
| 37
| 65,632.688
| 41,967.875
| null | 47
|
white
| 48.695313
| 101
| 0.011
| 0.002
| 1
| 0
| 0
|
yes
| 0.5
| 0.3
|
dnr after sadm
| 6
| 45
| 0.099991
| 140
| 30
| 38.69531
| 230
| 1.199951
| 4.899414
| 2.599609
| 149
| 7.449219
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 7
| 1
|
65.01794
|
male
| 1
| 3
|
Coma
|
Coma
| 1
| 14
|
>$50k
| 100
| 10,533.594
| 9,178.8906
| null | 28
|
white
| 36.5
| 57
| 0.004
| 0.001
| 1
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 2
| 73
| 14.398438
| 0
| 0
| 35.89844
| 270
| 3.699707
| 2.199707
| 1.599854
| 149
| 7.459961
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 3
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.